Thomas A. Munro

1.1k total citations
17 papers, 826 citations indexed

About

Thomas A. Munro is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Thomas A. Munro has authored 17 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 11 papers in Molecular Biology and 2 papers in Organic Chemistry. Recurrent topics in Thomas A. Munro's work include Neuropeptides and Animal Physiology (14 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Thomas A. Munro is often cited by papers focused on Neuropeptides and Animal Physiology (14 papers), Receptor Mechanisms and Signaling (10 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). Thomas A. Munro collaborates with scholars based in United States, Australia and Italy. Thomas A. Munro's co-authors include Mark A. Rizzacasa, Bruce M. Cohen, Cécile Béguin, William A. Carlezon, Bryan L. Roth, Wei Xu, Lee‐Yuan Liu‐Chen, Katharine K. Duncan, Feng Yan and Roy M. Robins‐Browne and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Thomas A. Munro

17 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas A. Munro United States 14 425 413 162 133 114 17 826
Philippe Vayer France 19 476 1.1× 521 1.3× 132 0.8× 112 0.8× 144 1.3× 28 1.4k
Ronald L Krall United States 9 349 0.8× 379 0.9× 373 2.3× 33 0.2× 39 0.3× 20 1.0k
Claire Mackie Belgium 25 371 0.9× 793 1.9× 189 1.2× 490 3.7× 89 0.8× 49 2.0k
Kevin Tidgewell United States 22 790 1.9× 838 2.0× 264 1.6× 207 1.6× 219 1.9× 40 1.4k
Monica Mazzarino Italy 21 95 0.2× 243 0.6× 35 0.2× 119 0.9× 63 0.6× 77 1.4k
Leander J. Valdés United States 11 346 0.8× 329 0.8× 167 1.0× 161 1.2× 133 1.2× 13 709
Andrea Chicca Switzerland 26 370 0.9× 473 1.1× 153 0.9× 99 0.7× 102 0.9× 57 1.6k
Matthew Schmidt United States 8 229 0.5× 326 0.8× 71 0.4× 78 0.6× 84 0.7× 11 463
Zhongze Ma United States 18 524 1.2× 862 2.1× 683 4.2× 141 1.1× 171 1.5× 32 1.5k

Countries citing papers authored by Thomas A. Munro

Since Specialization
Citations

This map shows the geographic impact of Thomas A. Munro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Munro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Munro more than expected).

Fields of papers citing papers by Thomas A. Munro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas A. Munro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Munro. The network helps show where Thomas A. Munro may publish in the future.

Co-authorship network of co-authors of Thomas A. Munro

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas A. Munro. A scholar is included among the top collaborators of Thomas A. Munro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas A. Munro. Thomas A. Munro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Munro, Thomas A.. (2023). Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72. BMC Biology. 21(1). 213–213. 3 indexed citations
2.
Himmelstein, Daniel, et al.. (2018). Sci-Hub provides access to nearly all scholarly literature. eLife. 7. 99 indexed citations
3.
Munro, Thomas A., Wei Xu, Douglas M. Ho, Lee‐Yuan Liu‐Chen, & Bruce M. Cohen. (2013). Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity. Beilstein Journal of Organic Chemistry. 9. 2916–2924. 7 indexed citations
4.
Munro, Thomas A., Xi‐Ping Huang, Carmela Inglese, et al.. (2013). Selective κ Opioid Antagonists nor-BNI, GNTI and JDTic Have Low Affinities for Non-Opioid Receptors and Transporters. PLoS ONE. 8(8). e70701–e70701. 58 indexed citations
5.
Schmid, Cullen L., John M. Streicher, Chad E. Groer, et al.. (2013). Functional Selectivity of 6′-Guanidinonaltrindole (6′-GNTI) at κ-Opioid Receptors in Striatal Neurons. Journal of Biological Chemistry. 288(31). 22387–22398. 75 indexed citations
6.
Munro, Thomas A., Douglas M. Ho, & Bruce M. Cohen. (2012). Salvinorin B methoxymethyl ether. Acta Crystallographica Section E Structure Reports Online. 68(11). o3225–o3226. 2 indexed citations
7.
Munro, Thomas A., Loren Berry, Ashlee Van’t Veer, et al.. (2012). Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. BMC Pharmacology. 12(1). 5–5. 76 indexed citations
8.
Mendelson, John, Jeremy Coyle, Matthew J. Baggott, et al.. (2010). Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial. Psychopharmacology. 214(4). 933–939. 24 indexed citations
9.
Hooker, Jacob M., Thomas A. Munro, Cécile Béguin, et al.. (2009). Salvinorin A and derivatives: Protection from metabolism does not prolong short-term, whole-brain residence. Neuropharmacology. 57(4). 386–391. 36 indexed citations
10.
Béguin, Cécile, Katharine K. Duncan, Thomas A. Munro, et al.. (2008). Modification of the furan ring of salvinorin A: Identification of a selective partial agonist at the kappa opioid receptor. Bioorganic & Medicinal Chemistry. 17(3). 1370–1380. 27 indexed citations
11.
Béguin, Cécile, David N. Potter, Jennifer A. DiNieri, et al.. (2007). N-Methylacetamide Analog of Salvinorin A: A Highly Potent and Selective κ-Opioid Receptor Agonist with Oral Efficacy. Journal of Pharmacology and Experimental Therapeutics. 324(1). 188–195. 37 indexed citations
12.
Munro, Thomas A., Katharine K. Duncan, Wei Xu, et al.. (2007). Standard protecting groups create potent and selective κ opioids: Salvinorin B alkoxymethyl ethers. Bioorganic & Medicinal Chemistry. 16(3). 1279–1286. 54 indexed citations
13.
Munro, Thomas A., Katharine K. Duncan, Richard J. Staples, et al.. (2007). 8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor. Beilstein Journal of Organic Chemistry. 3. 1–1. 84 indexed citations
14.
Munro, Thomas A., et al.. (2005). Autoxidation of Salvinorin A under Basic Conditions. The Journal of Organic Chemistry. 70(24). 10057–10061. 15 indexed citations
15.
Munro, Thomas A., et al.. (2004). Studies toward the Pharmacophore of Salvinorin A, a Potent κ Opioid Receptor Agonist. Journal of Medicinal Chemistry. 48(2). 345–348. 97 indexed citations
16.
Munro, Thomas A. & Mark A. Rizzacasa. (2003). Salvinorins D−F, New Neoclerodane Diterpenoids from Salvia divinorum, and an Improved Method for the Isolation of Salvinorin A. Journal of Natural Products. 66(5). 703–705. 73 indexed citations
17.
Munro, Thomas A., et al.. (2003). Divinatorins A−C, New Neoclerodane Diterpenoids from the Controlled Sage Salvia divinorum. Journal of Natural Products. 66(9). 1242–1244. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026